Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Variable Rate [Domain] Variable Rate [Domain] Net loss at subsidiary attributable to noncontrolling interests Net loss at subsidiary attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Entity Voluntary Filers Entity Voluntary Filers Total other current liabilities Accrued Liabilities, Current Schedule of accrued liabilities Schedule of Accrued Liabilities [Table Text Block] Range [Domain] Statistical Measurement [Domain] Inventory reserves, obsolescence and discontinuance Inventory Valuation Reserves Line of credit, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Research and development Research and Development Expense Net changes in assets and liabilities affecting operating activities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Stock options, expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Change in unpaid invoices for offering costs Change In Unpaid Invoices For Offering Costs Change In Unpaid Invoices For Offering Costs Schedule of net product revenues by product Revenue from External Customers by Products and Services [Table Text Block] Equity Award [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Remaining lease term (in years) Lessee, Operating Lease, Remaining Lease Term Nonvested, beginning of period (in shares) Nonvested, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Cumberland Emerging Technologies, Inc (CET) Cumberland Emerging Technologies, Inc [Member] Cumberland Emerging Technologies, Inc [Member] Decrease (increase) in cash surrender value of life insurance policies over premiums paid Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy Customer 1, 2, and 3 Customer 1, 2, and 3 [Member] Customer 1, 2, and 3 Debt Debt Disclosure [Text Block] Collaborative Arrangement, Transaction with Party to Collaborative Arrangement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Statement of Stockholders' Equity [Abstract] Cash paid for acquisition Payment to acquire business upon closing Payments to Acquire Businesses, Gross Research and Development Research and Development Expense, Policy [Policy Text Block] Defined contribution plan, employer discretionary contribution amount Defined Contribution Plan, Employer Discretionary Contribution Amount Revolving Credit Facility Revolving Credit Facility [Member] Impairment loss on intangible assets Impairment of Intangible Assets, Finite-Lived MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Computer equipment Computer Equipment [Member] Restatement Determination Date: Restatement Determination Date [Axis] Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Federal tax expense at statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Commitments and contingencies Commitments and Contingencies Operating Lease Liabilities, Payments Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Insider Trading Policies and Procedures [Line Items] Options exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Current portion of accrued contingent consideration Business Combination, Contingent Consideration, Liability, Accrued, Current Business Combination, Contingent Consideration, Liability, Accrued, Current Initial public offering, underwriting discounts Stock Issued During Period, New Shares, Underwriting Discounts Stock Issued During Period, New Shares, Underwriting Discounts Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Manufacturing agreements, number of primary suppliers for each product Manufacturing agreements, number of primary suppliers for each product Manufacturing agreements, number of primary suppliers for each product Depreciation, including amortization related to leasehold improvements Depreciation, Including Amortization Related to Leasehold Improvements Depreciation, Including Amortization Related to Leasehold Improvements Shareholders' Equity Equity [Text Block] Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Geographical [Axis] Geographical [Axis] Employment Agreements [Abstract] Employment Agreements [Abstract] Type of Arrangement and Non-arrangement Transactions [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Income Taxes Income Tax Disclosure [Text Block] Ownership [Axis] Ownership [Axis] Borrowings on line of credit Proceeds from (Repayments of) Lines of Credit Lessee, Operating Lease, Base Rent Lessee, Operating Lease, Base Rent Lessee, Operating Lease, Base Rent Life insurance policy proceeds received Proceeds from Life Insurance Policy Concentration Risk [Line Items] Concentration Risk [Line Items] Director Director [Member] Noncontrolling Interest [Abstract] Noncontrolling Interest [Abstract] Major Customers [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Federal Deferred Federal Income Tax Expense (Benefit) Business Acquisition [Line Items] Business Acquisition [Line Items] Weighted-average grant-date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Cash settlement of contingent consideration Payment for Contingent Consideration Liability, Financing Activities Forfeited/cancelled (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Diluted (in USD per share) Earnings Per Share, Diluted PEO Total Compensation Amount PEO Total Compensation Amount Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Line of Credit Line of Credit [Member] Outstanding, beginning of period (in shares) Outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number 2025-2042 Expiration, Term Two [Member] Expiration, Term Two [Member] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Granted (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Net loss attributable to common shareholders Net loss attributable to common shareholders Net loss attributable to common shareholders Net Income (Loss) Total current liabilities Liabilities, Current Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Change in unpaid invoices for intangible asset additions Purchases of Intangible Assets Incurred But Not Yet Paid Purchases of Intangible Assets Incurred But Not Yet Paid Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Leases Lessee, Operating Leases [Text Block] Expiration Time Period [Domain] Expiration Time Period [Domain] [Domain] for Expiration Time Period [Axis] LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Future minimum sublease income under noncancelable operating subleases Lessor, Operating Lease, Payment to be Received Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Repurchase of common shares Stock Repurchased During Period, Value Shareholders’ equity: Equity, Attributable to Parent [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Rebates, product returns, administrative fees and service fees Product Sales-Related Liabilities, Current Product Sales-Related Liabilities, Current Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Tiered royalty payments term (in years) Payments To Acquire Business, Tiered Royalty Payments, Term Payments To Acquire Business, Tiered Royalty Payments, Term Broadwest Lease, Five Year Renewal Option Broadwest Lease, Five Year Renewal Option [Member] Broadwest Lease, Five Year Renewal Option Total inventories Inventory, Gross Schedule of calculation of numerator and denominator in earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Trade and Note Receivables Receivable [Policy Text Block] Cost of products sold Cost of Goods and Services Sold Principal Owner Principal Owner [Member] Federal Internal Revenue Service (IRS) [Member] Tiered royalty payments, threshold Payments To Acquire Business, Tiered Royalty Payments, Threshold Payments To Acquire Business, Tiered Royalty Payments, Threshold Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Schedule of Inventory, Noncurrent Schedule of Inventory, Noncurrent [Table Text Block] Executive Category: Executive Category [Axis] Total cash paid included in measurement of lease liability Cash Payment Included In Measurement Of Lease Liability Cash Payment Included In Measurement Of Lease Liability Sales Revenue, Goods, Gross Sales Revenue, Goods, Gross [Member] Sales Revenue, Goods, Gross [Member] [Member] Number of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Vaprisol Vaprisol [Member] Vaprisol [Member] Milestone payment remaining Payments To Acquire Business, Milestone Payment Remaining Payments To Acquire Business, Milestone Payment Remaining Other Commitments [Table] Other Commitments [Table] Significant Accounting Policies Significant Accounting Policies [Text Block] Melinta Therapeutics, LLC and Targanta Therapeutics Corporation Melinta Therapeutics, LLC and Targanta Therapeutics Corporation [Member] Melinta Therapeutics, LLC and Targanta Therapeutics Corporation Exercised (in USD per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Milestone payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Milestone Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Milestone Payable Name Measure Name Patents Patents [Member] Name Forgone Recovery, Individual Name Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend Goodwill Goodwill Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Prepaid expense and other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Entity Small Business Entity Small Business Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Defined contribution plan, eligibility, minimum employee service time for participation eligibility Defined Contribution Plan, Eligibility, Minimum Employee Service Time for Participation Eligibility Defined Contribution Plan, Eligibility, Minimum Employee Service Time for Participation Eligibility 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Accounts Receivable Accounts Receivable [Member] Nephron Pharmaceuticals Corporation (“Nephron”) Nephron Pharmaceuticals Corporation (“Nephron”) [Member] Nephron Pharmaceuticals Corporation (“Nephron”) Common stock, par value (in dollars per share) Common Stock, No Par Value Following Approval Of First sNDA Following Approval Of First sNDA [Member] Following Approval Of First sNDA Operating lease non-current liabilities Operating lease non-current liabilities Operating Lease, Liability, Noncurrent Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Initial public offering, issuance costs Payments of Stock Issuance Costs Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Trademarks Trademarks [Member] Line of Credit Facility [Table] Line of Credit Facility [Table] Permanent differences associated with general business credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Net deferred tax assets, before valuation allowance Net Deferred Tax Assets, Gross Net Deferred Tax Assets, Gross Schedule of operating lease liability maturities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Customer 2 Customer Two [Member] Customer Two [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cost of Products Sold Cost of Goods and Service [Policy Text Block] Schedule of anti-dilutive securities excluded from computation of earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventories, net Increase (Decrease) in Inventories Number of renewal terms Lessee, Operating Lease, Number Of Renewal Terms Lessee, Operating Lease, Number Of Renewal Terms Caldolor Product - Caldolor [Member] Product - Caldolor Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Anti-dilutive shares and options (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Initial public offering, price per share Stock Issued During Period, Price Per Share, New Issues Stock Issued During Period, Price Per Share, New Issues Long-Term Incentive Compensation Plan 2007 Long-Term Incentive Compensation Plan 2007 [Member] Long-Term Incentive Compensation Plan 2007 [Member] Interest expense Interest Expense Unrecognized compensation costs Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Number of shares reserved for issuance under equity compensation plans Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Total property and equipment, gross Property, Plant and Equipment, Gross Quarterly Financial Information (Unaudited) Quarterly Financial Information [Text Block] Weighted-average remaining contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Lease liability obtained from right-of-use assets Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Cash payment of royalty during the period Payments for Royalties Stockholders' Equity Note [Abstract] Trading Arrangement: Trading Arrangement [Axis] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Less: Interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Cash contributions Share-based Compensation, Charitable Contribution of Shares, Cash Contributions Share-based Compensation, Charitable Contribution of Shares, Cash Contributions Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Schedule of the components of income tax benefit (expense) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Raw Materials Raw Materials [Member] Entity File Number Entity File Number Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] After 2028 Lessee, Operating Lease, Liability, to be Paid, after Year Five Pinnacle Bank Pinnacle Bank [Member] Pinnacle Bank [Member] Operating lease current liabilities Operating lease current liabilities Operating Lease, Liability, Current Deferred True-ups Effective Income Tax Rate Reconciliation, Deferred True-Ups, Percent Effective Income Tax Rate Reconciliation, Deferred True-Ups, Percent Auditor Firm ID Auditor Firm ID Amortization and impairment Amortization and impairment expense Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Recent Accounting Guidance New Accounting Pronouncements, Policy [Policy Text Block] Intangible assets, net Intangible assets, net Finite-Lived Intangible Assets, Net Restatement Determination Date Restatement Determination Date Valuation allowance for deferred tax assets: SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Milestone payments receivable, payment one Proceeds from Legal Settlements, Milestone Payments Receivable, Payment One Proceeds from Legal Settlements, Milestone Payments Receivable, Payment One Counterparty Name [Domain] Counterparty Name [Domain] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Current deferred charges Contract with Customer, Liability, Current Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Return of shares related to RediTrex Return of common stock - Methotrexate Stock Redeemed or Called During Period, Value Share-Based Payments Share-Based Payment Arrangement [Policy Text Block] 1600 West End Avenue Partners, LLC 1600 West End Avenue Partners, LLC [Member] 1600 West End Avenue Partners, LLC Stock Options Employee Stock Option [Member] Milestone payments receivable, number of payments Proceeds from Legal Settlements, Milestone Payments Receivable, Number of Payments Proceeds from Legal Settlements, Milestone Payments Receivable, Number of Payments Balance at beginning of period Balance at end of period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Unrecognized compensation cost related to share-based payments, period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total costs and expenses Expenses Costs and Expenses Maximum Maximum [Member] Unrecognized compensation cost related to share-based payments Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount WinHealth Investment (Singapore) Ltd WinHealth Investment (Singapore) Ltd [Member] WinHealth Investment (Singapore) Ltd Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Vibativ Product - Vibativ [Member] Product - Vibativ Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Inventories Inventory, Policy [Policy Text Block] Schedule of rent expense and sublease income Schedule of Rent Expense and Sublease Income [Table Text Block] Schedule of Rent Expense and Sublease Income [Table Text Block] Shareholder, percent Share-based Compensation Arrangement by Share-based Payment Award, Shareholder, Percent Share-based Compensation Arrangement by Share-based Payment Award, Shareholder, Percent Manufacturing and Supply Agreement [Table] Manufacturing and Supply Agreement [Table] Manufacturing and Supply Agreement [Table] Stock-Based Compensation Plans Share-Based Payment Arrangement [Text Block] Federal Current Federal Tax Expense (Benefit) Noncontrolling interest, ownership percentage by parent Subsidiary, Ownership Percentage, Parent Weighted- average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Leased area Lessee, Operating Lease, Leased Area Lessee, Operating Lease, Leased Area Business Acquisition [Axis] Business Acquisition [Axis] Accounts receivable, allowances, current Accounts Receivable, Allowance for Credit Loss, Current Operating loss carryforwards Operating Loss Carryforwards Customer Concentration Risk Customer Concentration Risk [Member] State Deferred State and Local Income Tax Expense (Benefit) Schedule of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other current liabilities Other Liabilities, Current Variable Rate [Axis] Variable Rate [Axis] Accounts payable and other current liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Inventory [Line Items] Inventory [Line Items] Raw materials Inventory, Raw Materials, Net of Reserves Initial public offering, shares issued Stock Issued During Period, Shares, New Issues Accounts Receivable, Allowances by Component [Domain] Accounts Receivable, Allowances by Component [Domain] [Domain] for Accounts Receivable, Allowances by Component [Axis] Costs and expenses: Costs and Expenses [Abstract] Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Rent increase Lessee, Operating Lease, Rent Increase Lessee, Operating Lease, Rent Increase Sublease Income Sublease Income Vibativ®, Sancuso® and RediTrex® Products Business Combination Disclosure [Text Block] Initial public offering, effective date Sale of Stock, Transaction Date Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Nonvested, beginning of period (in USD per share) Nonvested, end of period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Line Items] Share-based compensation Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Share consideration, value Collaborative Arrangement, Rights And Obligations, Stock Consideration, Value Collaborative Arrangement, Rights And Obligations, Stock Consideration, Value Class of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Other income - gain on insurance proceeds Insured Event, Gain (Loss) Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Inventories, net Total inventories Inventory, Net Revolving line of credit Borrowings outstanding under revolving credit facility Long-Term Line of Credit, Noncurrent Inventory Deferred Tax Assets, Inventory Active Pharmaceutical Ingredient ("API") And Work In Progress Active Pharmaceutical Ingredient ("API") And Work In Progress [Member] Active Pharmaceutical Ingredient ("API") And Work In Progress Range [Axis] Statistical Measurement [Axis] Non-current inventories less non-current inventories Inventory, Noncurrent Milestone payment credit due Collaborative Arrangement, Rights and Obligations, Milestone Payment, Credit Due Collaborative Arrangement, Rights and Obligations, Milestone Payment, Credit Due Employment Agreements Employment Agreements [Text Block] Employment Agreements Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Advertising Costs Advertising Cost [Policy Text Block] Deferred charges Deferred Tax Assets, Deferred Charges Deferred Tax Assets, Deferred Charges Total Shareholder Return Amount Total Shareholder Return Amount Payments made in connection with repurchase of common shares Payments for Repurchase of Common Stock Product Product [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Intangible Assets and Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Methotrexate Methotrexate [Member] Methotrexate [Member] Expiration Time Period [Axis] Expiration Time Period [Axis] Expiration Time Period [Axis] Noncash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Inventory Disclosure [Abstract] Deferred compensation assets Deferred Compensation Plan Assets Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Other income - settlement Gain (Loss) Related to Litigation Settlement Name Outstanding Recovery, Individual Name Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Initial public offering, gross proceeds Stock Issued During Period, Gross Proceeds from Initial Public Offering Stock Issued During Period, Gross Proceeds from Initial Public Offering Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Federal And State Federal And State [Member] Federal And State Current assets: Assets, Current [Abstract] Leases [Abstract] Other Commitments [Line Items] Other Commitments [Line Items] Advertising costs Advertising Expense Business Acquisition, Contingent Consideration [Line Items] Business Acquisition, Contingent Consideration [Line Items] Schedule of deferred tax assets and liabilities, net Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Continuing operations - basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding U.S. Product Asset Rights - Sancuso U.S. Product Asset Rights - Sancuso [Member] U.S. Product Asset Rights - Sancuso Shares cancelled and refunded Collaborative Arrangement, Rights And Obligations, Stock Consideration, Cancelled And Refunded Collaborative Arrangement, Rights And Obligations, Stock Consideration, Cancelled And Refunded PEO PEO [Member] Auditor Location Auditor Location Employee Benefit Plans Retirement Benefits [Text Block] Milestone payment Collaborative Arrangement, Rights and Obligations, Milestone Payment Collaborative Arrangement, Rights and Obligations, Milestone Payment Operating lease liabilities Deferred Tax Asset, Operating Lease Liabilities Deferred Tax Asset, Operating Lease Liabilities Stock options, exercise price as percent of weighted-average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price as Percent of Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price as Percent of Weighted Average Grant Date Fair Value Auditor Information [Abstract] Auditor Information Class of Stock [Domain] Class of Stock [Domain] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Name of Major Customer [Domain] Customer [Domain] Schedule of Inventory, Current Schedule of Inventory, Current [Table Text Block] Number of option shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Net loss tax expense Effective Income Tax Rate Reconciliation, Percent Schedule of quarterly financial information Quarterly Financial Information [Table Text Block] Total Present value of lease liabilities Operating Lease, Liability Deferred Tax Liabilities Deferred Tax Liabilities, Gross [Abstract] Credit Facility [Axis] Credit Facility [Axis] Total liabilities Liabilities Total current income tax expense Current Income Tax Expense (Benefit) Manufacturing and Supply Agreements Manufacturing and Supply Agreements [Text Block] Manufacturing and Supply Agreements Organization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Charged to costs and expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Schedule of Distribution Costs Schedule of Distribution Costs [Table Text Block] Schedule of Distribution Costs Shares available for future grants (in shares) Common Stock, Capital Shares Reserved for Future Issuance Property and Equipment Property, Plant and Equipment Disclosure [Text Block] All Executive Categories All Executive Categories [Member] Caldolor Caldolor [Member] Caldolor. Title of Individual [Axis] Title of Individual [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Plan Name [Axis] Plan Name [Axis] Capitalized research cost Deferred Tax Assets, in Process Research and Development Debt Disclosure [Abstract] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Related Party Transaction [Domain] Related Party Transaction [Domain] Loss per share attributable to common shareholders: Earnings per share attributable to common shareholders Earnings Per Share [Abstract] Selling and marketing Selling and Marketing Expense Vaprisol Product - Vaprisol [Member] Product - Vaprisol MIlestone payment Payments To Acquire Business, Milestone Payment Payments To Acquire Business, Milestone Payment General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Amortization of operating lease right-of-use asset Operating Lease, Right-of-Use Asset, Periodic Reduction Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] State and other Current State and Local Tax Expense (Benefit) Segment Reporting Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Initial investment amount Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Charitable contribution of shares (in shares) Share-based Compensation, Charitable Contribution of Shares, Shares Share-based Compensation, Charitable Contribution of Shares, Shares Beginning balance Ending balance Business Combination, Contingent Consideration, Liability Schedule of revenues concentration from major customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] All Individuals All Individuals [Member] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Omeclamox-Pak Product - Omeclamox-Pak [Member] Product - Omeclamox-Pak Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Non-current portion of accrued contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date Earnings (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Share repurchase program, number of shares authorized to be repurchased Stock Repurchase Program, Authorized Amount Intangible Assets and Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Repurchase of common shares (in shares) Repurchase of common shares (in shares) Stock Repurchased During Period, Shares Product Sales Related Allowances - Chargebacks, Cash Discounts and Damaged Goods Chargebacks, Cash Discounts and Damaged Goods [Member] Chargebacks, Cash Discounts and Damaged Goods [Member] Schedule of effective tax rate reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] PEO Name PEO Name Concentration risk, percentage Concentration Risk, Percentage Manufacturing and Supply Agreements [Abstract] Manufacturing and Supply Agreements [Abstract] Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Preferred stock, shares authorized Preferred Stock, Shares Authorized Summary of tax credit carryforwards Summary of Tax Credit Carryforwards [Table Text Block] State income tax expense (net of federal income tax benefit) Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Nordic Group B.V. Nordic Group B.V. [Member] Nordic Group B.V. Quarterly Financial Information Disclosure [Abstract] Granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Accounts Receivable Accounts Receivable [Policy Text Block] Maximum increase to line of credit Line Of Credit Facility, Additional Borrowing Capacity Line Of Credit Facility, Additional Borrowing Capacity Cumulative compensation costs incurred on deductible equity awards Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Schedule of expected amortization expense of intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Current portion of accrued contingent consideration Business Combination, Contingent Consideration, Liability, Current Entities [Table] Entities [Table] Tiered royalty payments (percentage) Payments To Acquire Business, Tiered Royalty Payments, Percentage Payments To Acquire Business, Tiered Royalty Payments, Percentage Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] 2024 Expiration, Term One [Member] Expiration, Term One [Member] Other Other Accrued Liabilities, Current Other income Other Income SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Depreciation and amortization expense Depreciation, Depletion and Amortization Deferred Tax Assets Deferred Tax Assets, Gross [Abstract] Furniture and fixtures Furniture and Fixtures [Member] Interest rate Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Entity Information [Line Items] Entity Information [Line Items] Statement of Financial Position [Abstract] Allowance for uncollectible amounts, cash discounts, chargebacks, and credits issued for damaged products: SEC Schedule, 12-09, Allowance, Credit Loss [Member] Postemployment Benefits [Abstract] Business Combination and Asset Acquisition [Abstract] Total shareholders’ equity Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Goodwill, impairment loss Goodwill, Impairment Loss Less: deferred tax asset valuation allowance Deferred Tax Assets, Valuation Allowance Restricted Stock Restricted Stock [Member] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Additions to intangible assets Additions to intangible assets Payments to Acquire Intangible Assets Customer 1 Customer One [Member] Customer One [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Entity Emerging Growth Company Entity Emerging Growth Company Acetadote Product - Acetadote [Member] Product - Acetadote Kristalose Product - Kristalose [Member] Product - Kristalose Total deferred tax assets Deferred Tax Assets, Gross Sancuso Product - Sancuso [Member] Product - Sancuso Contingent liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability HongKong WinHealth Pharma Group Co. Limited HongKong WinHealth Pharma Group Co. Limited [Member] HongKong WinHealth Pharma Group Co. Limited Charged to other accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Study Drug Study Drug [Member] Study Drug Increase (Decrease) in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Reserve for expired product Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves for Expired Product Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves for Expired Product Investment in CET Subsidiary Investment, Purchase Of Shares Subsidiary Investment, Purchase Of Shares Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Other Products Other Products [Member] Other Products Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Title Trading Arrangement, Individual Title Rent expense Operating Lease, Expense Outstanding, beginning of period (in USD per share) Outstanding, end of period (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Common stock Common Stock Common Stock [Member] Individual: Individual [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Total deferred income tax expense Deferred Other Tax Expense (Benefit) Loss Per Share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Number of equity compensation plans available for future grants Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Available for Future Grants Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans Available for Future Grants Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Term of contract Lessee, Operating Lease, Term of Contract Inventory [Domain] Inventory [Domain] Minimum Minimum [Member] Proceeds from litigation settlement Proceeds from Legal Settlements Weighted-average shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Property and equipment, net Total property and equipment, net Property, Plant and Equipment, Net Share-Based Payment Arrangement, Option, Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Area of real estate property Area of Real Estate Property Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Other Manufactured Product, Other [Member] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Defined contribution plan, eligibiilty, minimum employee age Defined Contribution Plan, Eligibility, Minimum Employee Age Defined Contribution Plan, Eligibility, Minimum Employee Age Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Net loss Net loss Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income taxes Income Taxes Paid, Net Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Collaborative Arrangement, Milestone Payment, Threshold [Axis] Collaborative Arrangement, Milestone Payment, Threshold [Axis] Collaborative Arrangement, Milestone Payment, Threshold Continuing operations - diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated deficit Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and equity Liabilities and Equity RediTrex forgiveness of milestone payable Credit Issued for Milestone Payable Credit Issued for Milestone Payable Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Martin S. Brown Jr.'s Law Firm Martin S. Brown Jr.'s Law Firm [Member] Martin S. Brown Jr.'s Law Firm Ownership [Domain] Ownership [Domain] Risk free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Schedule of depreciation expense Schedule of Depreciation Expense [Table Text Block] Schedule of Depreciation Expense [Table Text Block] Basic (in USD per share) Earnings Per Share, Basic Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Disposal of assets Gain (Loss) on Disposition of Assets Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Customer 3 Customer Three [Member] Customer Three [Member] Net deferred tax assets Deferred Tax Assets, Net Sales milestone payments, receivable Collaborative Arrangement, Rights and Obligations, Sales Milestone Payments, Receivable Collaborative Arrangement, Rights and Obligations, Sales Milestone Payments, Receivable Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Related Party Related Party [Member] Inventory, Current [Table] Inventory, Current [Table] Principles of Consolidation Consolidation, Policy [Policy Text Block] Distribution costs Production and Distribution Costs Schedule of Business Acquisitions by Acquisition, Contingent Consideration Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] Net operating loss and tax credits Deferred Tax Assets, Operating Loss Carryforwards and Tax Credit Carryforwards Deferred Tax Assets, Operating Loss Carryforwards and Tax Credit Carryforwards Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Operating lease right-of-use assets Deferred Tax Liability, Operating Lease Right-of-Use Assets Deferred Tax Liability, Operating Lease Right-of-Use Assets Consigned inventory Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Amount available under current repurchase program Stock Repurchase Program, Remaining Authorized Repurchase Amount Termination Date Trading Arrangement Termination Date Federal Grant Programs Federal Grant Programs [Member] Collaborative Arrangement, Federal Small Business Grant Programs [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Milestone payments receivable, payment two Proceeds from Legal Settlements, Milestone Payments Receivable, Payment Two Proceeds from Legal Settlements, Milestone Payments Receivable, Payment Two Accounts Receivable, Allowances by Component [Axis] Accounts Receivable, Allowances by Component [Axis] Accounts Receivable, Allowances by Component [Axis] Noncash gain on RediTrex transaction Noncash or Part Noncash, Gain on Transaction Noncash or Part Noncash, Gain on Transaction Entity Public Float Entity Public Float Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Property, Plant and Equipment [Abstract] Other Liabilities Disclosure [Abstract] Adjustments to reconcile net loss to net cash flows provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Kristalose Kristalose [Member] Kristalose. All Adjustments to Compensation All Adjustments to Compensation [Member] Common stock – no par value; 100,000,000 shares authorized; 14,121,833 and 14,366,316 shares issued and outstanding as of December 31, 2023 and 2022, respectively Common Stock, Value, Outstanding Award Timing Disclosures [Line Items] Title of Individual with Relationship to Entity [Domain] Title of Individual [Domain] Compensation Amount Outstanding Recovery Compensation Amount Finished Goods Finished Goods [Member] Finished Goods Fair value of vested awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Schedule of balance sheet classification Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee Inventory [Axis] Inventory [Axis] Forfeited (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Other Accounts Payable and Accrued Liabilities, Noncurrent Collaborative Agreements Collaborative Arrangement, Accounting Policy [Policy Text Block] Directors’ Incentive Plan 2007 Directors’ Incentive Plan 2007 [Member] Directors’ Incentive Plan 2007 [Member] Income Taxes Income Tax, Policy [Policy Text Block] Prepaid and other current assets Prepaid Expense and Other Assets, Current Document Financial Statement Error Correction Document Financial Statement Error Correction [Flag] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Insider Trading Arrangements [Line Items] Manufacturing and Supply Agreement [Line Items] Manufacturing and Supply Agreement [Line Items] [Line Items] for Manufacturing and Supply Agreement [Table] NonPrincipal Owner NonPrincipal Owner [Member] NonPrincipal Owner [Member] Share-based compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Product and License Rights Product and License Rights [Member] Product and License Rights [Member] Share consideration vested, value Collaborative Arrangement, Rights And Obligations, Stock Consideration Vested, Value Collaborative Arrangement, Rights And Obligations, Stock Consideration Vested, Value Other Liabilities, Current [Abstract] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Expiration period (in years) Line of Credit Facility, Expiration Period Other current assets and other assets Increase (Decrease) in Other Operating Assets 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Adjustment to Compensation, Amount Adjustment to Compensation Amount Decrease in non-cash contingent consideration Change in fair value Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Lease Contractual Term [Axis] Lease Contractual Term [Axis] Noncontrolling interests Equity, Attributable to Noncontrolling Interest Expiring tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Auditor Name Auditor Name Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Sancuso related liabilities Accrued Liabilities, Stock Payable Accrued Liabilities, Stock Payable Entity Central Index Key Entity Central Index Key Return of RediTrex Proceeds from Collaborative Arrangement Proceeds from Collaborative Arrangement Market Concentrations Concentration Risk Disclosure [Text Block] Stock compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Intangible assets, gross Finite-Lived Intangible Assets, Gross Income tax expense Total income tax expense Income Tax Expense (Benefit) Deferred compensation liability Deferred Compensation Liability, Current and Noncurrent Finished goods, net of reserve Inventory, Finished Goods, Net of Reserves Non-US Non-US [Member] Deferred compensation Deferred Compensation Liability, Classified, Noncurrent Income Tax Authority [Domain] Income Tax Authority [Domain] Employee wages and benefits Employee-related Liabilities, Current Sancuso Sancuso [Member] Sancuso Schedule of federal and state net operating loss carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Number of operating segments Number of Operating Segments Name Trading Arrangement, Individual Name Lender Name [Axis] Lender Name [Axis] Inventories, Net Inventory Disclosure [Text Block] Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Risks and Uncertainties [Abstract] Net revenues Revenues Revenue from Contract with Customer, Excluding Assessed Tax Entity [Domain] Entity [Domain] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Inventory, Noncurrent [Table] Inventory, Noncurrent [Table] Inventory, Noncurrent Amendment Flag Amendment Flag Legal Entity [Axis] Legal Entity [Axis] Intangible assets Deferred Tax Assets, Goodwill and Intangible Assets Deposit payment Collaborative Arrangement, Rights And Obligations, Deposit Payment Collaborative Arrangement, Rights And Obligations, Deposit Payment Total federal and state credit carryforwards Tax Credit Carryforward, Amount Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Payments on line of credit Repayments of Notes Payable Weighted-average incremental borrowing rate Operating Lease, Weighted Average Discount Rate, Percent Accrued inventory purchases Accrued Liabilities, Inventory Purchases Accrued Liabilities, Inventory Purchases SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Interest Interest Paid, Excluding Capitalized Interest, Operating Activities Other permanent differences Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Credit Facility [Domain] Credit Facility [Domain] Basis spread on variable rate (in percent) Debt Instrument, Basis Spread on Variable Rate Property and equipment, useful life Property, Plant and Equipment, Useful Life Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Leasehold Improvements Leasehold Improvements [Member] Contingent consideration earned and accrued Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses Business Combination, Contingent Consideration, Earned and Accrued in Operating Expenses Diluted (in shares) Weighted-average shares outstanding – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Intangible assets, other than goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Schedule of other long-term liabilities Other Noncurrent Liabilities [Table Text Block] Settlement of patent litigation Proceeds from Settlement of Patent Litigation Proceeds from Settlement of Patent Litigation Net cash paid during the year for: Cash Paid During Year [Abstract] Cash Paid During Year For [Abstract] Revenues Revenue from Contract with Customer [Text Block] Additions to property and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Document Annual Report Document Annual Report Allowance for accounts receivable Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Options vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Cover [Abstract] Business Combination, Contingent Consideration, Liability [Roll Forward] Business Combination, Contingent Consideration, Liability [Roll Forward] Business Combination, Contingent Consideration, Liability Schedule of Advertising Costs Schedule of Advertising Costs [Table Text Block] Schedule of Advertising Costs Noncash interest expense Amortization of Debt Issuance Costs 2028 and thereafter Finite-Lived Intangible Assets, Amortization Expense, Year Four and After Finite-Lived Intangible Assets, Amortization Expense, Year Four and After Inventory, Noncurrent [Line Items] Inventory, Noncurrent [Line Items] Inventory, Noncurrent [Line Items] Other Current and Other Long-term Liabilities Other Liabilities Disclosure [Text Block] Grant Grant [Member] Total other long-term liabilities Total other long-term liabilities Other Liabilities, Noncurrent Vested (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Forfeited/cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share consideration (in shares) Collaborative Arrangement, Rights And Obligations, Stock Consideration, Shares Collaborative Arrangement, Rights And Obligations, Stock Consideration, Shares Gain on receipt of life insurance policies Other Nonoperating Gains (Losses) Collaborative Arrangement, Milestone Payment, Threshold [Domain] Collaborative Arrangement, Milestone Payment, Threshold [Domain] Collaborative Arrangement, Milestone Payment, Threshold [Domain] Return of common stock - Methotrexate (in shares) Stock Redeemed or Called During Period, Shares Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Renewal term Lessee, Operating Lease, Renewal Term Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] State State and Local Jurisdiction [Member] Indefinite Period Indefinite [Member] Indefinite Prepaid and Other Current Assets Prepaids and Other Current Assets, Policy [Policy Text Block] Prepaids and Other Current Assets, Policy [Policy Text Block] Text Block [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Basic (in shares) Weighted-average shares outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Studies accrual Accrued Liabilities, Studies Accrued Liabilities, Studies Operating loss Operating income (loss) Operating Income (Loss) Property and equipment and intangibles Deferred Tax Assets, Property and Equipment and Intangibles Deferred Tax Assets, Property and Equipment and Intangibles Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Product Assets And Global Rights - Vibativ Product Assets And Global Rights - Vibativ [Member] Product Assets And Global Rights - Vibativ Vibativ Vibativ [Member] Vibativ Initial public offering, net proceeds Proceeds from Issuance Initial Public Offering Office equipment Office Equipment [Member] Revenues: Revenues [Abstract] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Related Party Transaction [Axis] Related Party Transaction [Axis] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Office Building Office Building [Member] Intangible assets Deferred Tax Liabilities, Intangible Assets Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Within 30 Days Of First sNDA Filing Within 30 Days Of First sNDA Filing [Member] Within 30 Days Of First sNDA Filing Shelf Registration, sale of corporate securities (up to) Stock Issued During Period, Shelf Registration, Proceeds From Sale of Corporate Securities Stock Issued During Period, Shelf Registration, Proceeds From Sale of Corporate Securities Equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] RediTrex Product - RediTrex [Member] Product - RediTrex Non-controlling interest Noncontrolling Interest [Member]